Chipotle Testing Smoked Brisket In Cincinnati And Sacramento

Chipotle Mexican Grill, Inc. (CMG) said Monday it is testing Smoked Brisket at 64 restaurants throughout Cincinnati and part of Sacramento, California.

The Mexican food chain noted that its latest protein option features smoked beef brisket seasoned with a special spice blend, seared on the grill every day, and finished with a sauce made with Mexican peppers.

Smoked Brisket will be available for in-restaurant, online, mobile, and contactless delivery orders at participating locations for a limited time.

Chipotle said it is using the stage-gate process to test and learn from customer feedback, and iterate before it decides on a national launch strategy.

In 2019 and 2020, Chipotle successfully completed the stage-gate process and rolled out three Chipotle menu items, Carne Asada, Supergreens Salad Mix and Queso Blanco, on a national scale.

In mid-July, Chipotle said it is testing Cilantro-Lime Cauliflower Rice at 55 restaurants in Denver and throughout Wisconsin, in addition to a digital-only quesadilla in Cleveland and Indianapolis.

The company, in late July, introduced new certified organic Lemonades, Aguas Frescas, and Teas from farmer-founded Tractor Beverage Co. across all its U.S. restaurants.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT